Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Experimental group:Yaoshan Qingwen Jiedu granules, Yaoshan Qingwen oral spray
Control group:Symptomatic management according to the national COVID-19 diagnosis and treatment protocol
Sponsors
Beijing Yao Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 95 Years
Inclusion criteria
Inclusion criteria: 1. Confirmed novel coronavirus infection with positive nucleic acid test; 2. Patients aged >=18 years, no gender limit; 3. Asymptomatic or mild clinical presentation; 4. Patients and family members complied with the treatment protocol, voluntarily accepted the study, and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant patients; 2. Those allergic to therapeutic drugs; 3. Infected persons or their family members cannot take medication according to the prescribed regimen.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of days of hospitalization required for secondary negative nucleic acid test;Nucleic acid repositive rate after discharge; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sex difference of nucleic acid conversion;Age difference in nucleic acid turning negative; | — |
Countries
China
Contacts
Public ContactQin Xunyun
Outcome results
None listed